Pharma Journalist -

After the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn Beta, the vaccine was approved by the European…
Read More...

Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. announced a brand new partnership focused on developing and sharing best practices in innovative manufacturing, product…
Read More...

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the PD-1 inhibitor Libtayo (cemiplimab-rwlc) in combination with platinum-based…
Read More...

NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, announced the closing of a £16 million Series A financing, led by Omega Funds and joined…
Read More...

Royalty Pharma plc and Arrowhead announced that Royalty Pharma has acquired a royalty interest in Amgen’s olpasiran from Arrowhead Pharmaceuticals for $250 million in cash upfront plus…
Read More...

A wholly-owned subsidiary of Sun Pharmaceutical Industries Limited and Sun Pharma Advanced Research Company Ltd. announced the signing of a licensing agreement for commercialization of…
Read More...

ProPhase Labs, Inc. announced that its wholly owned subsidiary, ProPhase BioPharma, Inc. (“PBIO”), and Dana-Farber Cancer Institute have entered into a two-year collaborative agreement…
Read More...

Following European Commission approval earlier this month, the Medicines and Healthcare products Regulatory Agency (MHRA) has approved Beyfortus (nirsevimab) for the prevention of…
Read More...

Immunomic Therapeutics, Inc. (ITI), a privately-held clinical-stage biotechnology company pioneering the development of LAMP-mediated nucleic acid-based immunotherapy, announced that…
Read More...

Bruker Corporation announced the acquisition of Inscopix, Inc., a neuroscience pioneer and market leader of miniaturized microscopes, known as miniscopes, for freely moving animal brain…
Read More...